Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jul 29;16(7):e0254831. doi: 10.1371/journal.pone.0254831

Amblyopia risk factors among pediatric patients in a hospital-based setting using photoscreening

Christiane Al-Haddad 1,*, Zeinab El Moussawi 1, Stephanie Hoyeck 1, Carl-Joe Mehanna 1, Nasrine Anais El Salloukh 1, Karine Ismail 1, Mona Hnaini 2, Rose-Mary N Boustany 2
Editor: Ahmed Awadein3
PMCID: PMC8320995  PMID: 34324539

Abstract

Purpose

The aim of our study was to determine the prevalence of amblyopia risk factors in children visiting the American University of Beirut Medical Center (AUBMC) using automated vision screening.

Methods

This was a hospital-based screening of 1102 children aged between 2 and 6 years. Vision screening was performed using PlusoptiX S12 over 2 years (2018–2020). The need for referral to a pediatric ophthalmologist was based on the amblyopia risk factors set forth by the American Association for Pediatric Ophthalmology and Strabismus. Referred patients underwent a comprehensive eye examination.

Results

A total of 1102 children were screened, 63 were referred for amblyopia risk factors (5.7%); 37/63 (59%) underwent comprehensive eye examination and 73% were prescribed glasses. Of the non-referred group of children, 6.35% had astigmatism, 6.25% were hyperopic and 3.27% were myopic. The refractive errors observed among the examined patients were distributed as follows: 41% astigmatism, 51% hyperopia, and 8% myopia; amblyopia was not detected. Refractive amblyopia risk factors were associated with the presence of systemic disorders. Bland-Altman plots showed most of the differences to be within limits of agreement.

Conclusion

Using an automated vision screener in a hospital-based cohort of children aged 2 to 6 years, the rate of refractive amblyopia risk factors was 5.7%. Hyperopia was the most commonly encountered refractive error and children with systemic disorders were at higher risk.

Introduction

Early childhood vision screening is recommended for detecting preventable and treatable vision disorders [1–3]. Amblyopia is a common cause of decreased vision in children [4–11]. Early diagnosis through vision screening, referrals for complementary examinations and early interventions lead to better visual outcomes [4]. The US Preventive Services Task Force recommends vision screening at least once in all children aged 3 to 5 years to detect amblyopia or its risk factors [2]. The American Academy of Ophthalmology (AAO) and the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) [12] recommend vision screening during the preschool years [3]. Instrument-based screening is recommended for all children aged 12 months and above undergo [3, 13]. In one study, photoscreening was superior to optotype-based screening for children between the ages of 3 and 6 years [14]. In addition, children screened and referred before the age of 2 years were more likely to reach a visual acuity of 20/40, as compared to those screened after age 2 [15].

One of the recent automated screeners is PlusoptiX; it is a digital portable photoscreener that gives a non-cycloplegic autorefraction of undilated pupils [16]. PlusoptiX has shown a sensitivity ranging from 92.86% to 100% and a specificity ranging from 49.57% to 94.49% in the detection of refractive amblyopia risk factors [17]. A recent study compared three photoscreening devices, iScreen, PlusoptiX and SPOT photoscreeners: sensitivity overall for detection of amblyogenic factors ranged from 72% (iScreen) to 84% (PlusoptiX), and specificity ranged from 68% (SPOT) to 94% (PlusoptiX) [18].

In studies from several parts of the world, the prevalence of refractive errors in children showed a wide range [17, 19]. The subtypes of refractive risk factors were: 3.5% to 30.5% for hyperopia, 4.9% to 53.1% for myopia and 22% to 25.5% for astigmatism [19–25].

There is scarce literature on the prevalence of refractive amblyopia risk factors in the Middle East, and more specifically in Lebanon. The aim of our study was to detect refractive amblyopia risk factors in children visiting the American University of Beirut Medical Center for a routine check-up at the pediatrics clinics, using the PlusoptiX S12 photoscreener, and to correlate results with age, sex, systemic disorders and prematurity.

Methods

Population

This was a hospital-based screening of 1102 children, aged 2 to 6 years, visiting the general pediatric clinics of the American University of Beirut Medical Center (Out-Patient Division and private clinics). The study was approved by the Institutional Review Board (IRB) at the American University of Beirut Medical Center (IRB ID: OPH.CH.20) and was conducted over a 2 year period from 2018 to 2020. Written informed consent was obtained from parents or legal guardians. The study adhered to the principles of the Declaration of Helsinki. Demographic data were collected from the parents, including date of birth, prematurity, presence of any known eye disease, and past medical history of any systemic disease.

Vision screening

Vision screening was performed by personnel who had received a three-hour-training session on the use of the PlusoptiX S12 photoscreener (PlusoptiX GmbH, Atlanta, GA). Performing vision screening was simple: the camera was set off by pulling the trigger. The sound attracted attention and both eyes were captured on screen in a white rectangle and measurement was automatically registered. Screening results were immediately displayed on the screen and data on refraction (sphere, cylinder and axis) of each eye were recorded. Spherical equivalent (SE) refraction in diopters (D) was then calculated. If the primary screening attempt failed, screening was repeated up to three times.

If the screening revealed refractive errors, subjects were referred to the pediatric ophthalmology clinic (author CA) according to the age-based criteria for amblyopia risk factor detection guidelines set by the American Association of Pediatric Ophthalmology and Strabismus Vision Screening Committee (Table 1) [26].

Table 1. AAPOS amblyopia risk factors targeted with automated preschool vision screening [26].

Age, months Astigmatism Hyperopia Anisometropia Myopia
12–30 >2.00D >4.50D >2.50D > -3.50D
31–48 >2.00D >4.00D >2.00D > -3.00D
>48 >1.50D >3.50D >1.50D > -1.50D

D: Diopters

Eye examination

To confirm the results of the vision screening when positive, a comprehensive pediatric eye examination was performed by the same attending pediatric ophthalmologist (author CA). This entailed age-dependent visual acuity testing: “central steady & maintained” testing for preverbal children and vision charts (Allen pictures and Early Treatment Diabetic Retinopathy Study charts (EDTRS)) for verbal children. Anterior segment examination, motility examination for any eye misalignment, and posterior segment examination using indirect ophthalmoscopy were performed. Cycloplegic manual retinoscopy was done to detect refractive errors (30 minutes after pupillary dilation with Mydriacyl 1% and Cyclopentolate 1%, applied twice 10 minutes apart; in this clinic, we use two sets as a standard especially with darker irides). Significant astigmatism was defined as cylindrical power of 1D or more with the main refractive error being the cylinder. Those reported with hyperopia and myopia had mainly spherical refractive error (>+1D or <-1D, respectively).

Statistical analysis

After obtaining complete data, statistical analysis was performed using SPSS (Statistical Packages for Social Sciences) v 24, where frequencies and descriptive statistics were computed. Correlations were established using independent t-tests, bivariate (Pearson) correlation, intraclass correlation coefficient (ICC) score. Significance level was set at a p-value of less than 0.05. Bland-Altman analysis was performed by calculating the difference between spherical equivalent values obtained by PlusoptiX and by cycloplegic refraction for each eye, plotted against the average of the two values. Horizontal dashed lines were drawn at the 95% limits of agreement, which were defined as the mean difference ±1.96 x standard deviation of the differences.

Results

Characteristics of study population

A total of 1102 children aged 2 to 6 years were screened using the PlusoptiX S12 vision screener. Mean age of the studied population was 4.13 ± 1.44 years, with 511 females (46%). Twenty-one of included subjects (1.9%) were born prematurely (gestational age below 37 weeks), and 93 (8.4%) had associated systemic disorders. The mean SE refraction was 0.39 ± 0.74D for right eyes, and 0.40 ± 0.71D for left eyes. The prevalence of refractive amblyopia risk factors was 5.7%, where 63 subjects were referred for full eye examination according to the AAPOS age-appropriate refractive error targets (Table 1).

Among the 63 subjects who met the criteria for referral, 37 (59%) were examined at the pediatric ophthalmology clinic of our department (by author CA). The rest (41%) were lost to follow up after multiple attempts to schedule an ophthalmology appointment.

Mean age of the referred group was 4.24±1.48 years, with no statistically significant difference compared to that of the whole population studied: 28 were females (44.5%),1 was premature (1.6%) and 14 had associated systemic disorders (22.2%). According to the screening exam with the automated vision screener, mean SE was 0.75 ± 1.68D for right eyes, and 0.74 ± 1.67D for left eyes, similar to those for the whole group (Table 2). After cycloplegic refraction for this group, the detected refractive errors were as follows: 41% astigmatism (mean cylinder 2.04±0.85D), 51% hyperopia (mean SE +3.28±2.79D), and 8% myopia (mean SE -2.25±1.89D). Of the examined subjects, 27 (73%) were prescribed glasses. Of the non-referred group of children with minimal refractive errors not reaching the AAPOS threshold values, automated vision screening revealed astigmatism in 66 (6.35%) with mean cylinder of 1.24 ± 0.27D, hyperopia in 65 (6.25%) with mean SE of +1.31 ± 0.42D and myopia in 34 (3.27%) with mean SE of -1.42 ± 0.44D.

Table 2. Demographics of the studied population compared to the demographics of the population subgroup requiring referral to a comprehensive eye exam.

Total Referred P-value*
N = 1102 N = 63
Mean age ± SD (years) 4.13±1.44 4.24±1.48 0.63
Gender Female, n (%) 511 (46%) 28 (44.5%) 0.76
Premature, n (%) 21 (1.9%) 1 (1.6%) 0.86
Systemic disorders, n (%) 93 (8.4%) 14 (22.2%) < 0.001
Hematologic 22 4
Neurologic 22 3
Cardiac 15 4
Metabolic 15 2
Respiratory 12 1
Immunologic/Rheumatologic 5 0
Syndromic 2 0
Range of spherical equivalent (in D)
OD (-3.88)–(+4.50)
OS (-3.88)–(+3.75)
Mean spherical equivalent refraction ± SD (in D)
OD 0.39 ± 0.74 0.75 ± 1.68 0.15
OS 0.40 ± 0.71 0.74 ± 1.67 0.15

*p-values comparing the referred group to the total

Comparison between the plusoptiX and cycloplegic retinoscopy

The plusoptiX and CR results are compared in Table 3. For the whole examined population (n = 37), a significant difference was seen for the sphere (p<0.001) and the mean SE (p = 0.02), with a difference of 1.21 ± 2.61D and 0.54 ± 2.48D, respectively. The intraclass correlation coefficient (ICC) score of the SE between Plusoptix and cycloplegic refraction was 0.70. Out of the 37 examined children, 19 had hyperopia, 15 had astigmatism and 3 subjects were myopic. When looking at each refractive error separately, the difference between cycloplegic refraction and PlusoptiX was only significant for the sphere and SE of the hyperopic population, with a difference of 2.26 ± 1.30D and 1.84 ± 1.40D, respectively (p<0.05 for both). Screening results and cycloplegic refraction were similar for myopia and astigmatism. In addition, the Bland-Altman plot was generated to further assess the agreement in measured spherical equivalent between PlusoptiX and CR for each eye (Fig 1). According to this analysis, the scatters tended to be within the limits of agreement.

Table 3. Comparison between the plusoptiX and cycloplegic retinoscopy of the examined population.

Sphere (D) Cylinder (D) SE (D)
Mean ± SD p-values Mean ± SD p-values Mean ± SD p-values
Total (n = 37)
CRx 1.68 ± 2.75 <0.001 1.31 ± 1.07 0.27 1.47 ± 2.40 0.023
PlusoptiX 0.47 ± 1.27 1.44 ± 0.99 0.93 ± 1.57
Difference 1.21 ± 2.61 0.13 ± 0.98 0.54 ± 2.48
Astigmatism (n = 15)
CRx 0.75 ± 0.84 0.14 2.04 ± 0.85 0.80 1.77 ± 0.99 0.18
PlusoptiX 0.30 ± 0.80 1.96 ± 0.90 1.28 ± 1.00
Difference 0.45 ± 0.04 0.08 ± 0.05 0.49 ± 0.01
Hyperopia (n = 19)
CRx 3.11 ± 2.70 0.0026 0.81 ± 0.90 0.21 3.28 ± 2.80 0.01
PlusoptiX 0.85 ± 1.40 1.18 ± 0.90 1.44 ± 1.40
Difference 2.26 ± 1.30 0.37 ± 0.00 1.84 ± 1.40
Myopia (n = 3)
CRx -2.67 ± 2.40 0.32 0.83 ± 1.10 0.61 -2.25 ± 1.90 0.28
PlusoptiX -1.04 ± 0.83 0.46 ± 0.44 -0.81 ± 0.65
Difference 1.63 ± 1.57 0.37 ± 0.66 1.44 ± 1.25

SE: Spherical equivalent; CRx: Cycloplegic Retinoscopy; NA: not applicable.

Difference is absolute cycloplegic minus PlusoptiX values.

Fig 1. Bland-Altman plot of spherical equivalent values of the right eye (OD) (A) and the left eye (OS) (B) in diopters.

Fig 1

The difference between the mean spherical equivalent as measured by PlusoptiX and mean spherical equivalent as measured by cycloplegic retinoscopy are plotted on the y-axis, and the mean spherical equivalent value obtained by the two measurements on the x-axis. Dashed lines represent the upper and lower 95% limits of agreement.

Correlation between refractive errors and risk factors, age, and sex

To assess correlation between each demographic factors and the prevalence of amblyopia risk factors, a bivariate (Pearson) correlation was performed. A statistically significant correlation was seen between systemic disorders (mostly hematologic, neurologic, cardiac and metabolic disorders) and prevalence of amblyopia risk factors with p<0.001; however this correlation was a weak one (Pearson correlation = 0.13). On the other hand, no significant correlation was seen between prematurity and referral in our small cohort (p = 0.86). There was no significant correlation between detection of amblyopia risk factors and age (p = 0.63), nor with gender (p = 0.76). The distribution of refractive errors varied with age, this is demonstrated in Fig 2. Hyperopia was the most commonly encountered refractive error overall especially in the older age group.

Fig 2. The distribution of refractive errors according to age in the examined population.

Fig 2

Discussion

This study reported amblyopia risk factors in Lebanese children aged 2 to 6 years in a hospital-based setting using automated vision screening. The referral rate for full eye exam was 5.7%. Out of those examined, 73% needed glasses. The refractive amblyopia risk factors as detected by the PlusoptiX screener were myopia in 0.3% hyperopia in 1.7% and astigmatism in 1.4%. Among the referred and examined subjects, the distribution of refractive errors as confirmed by cycloplegic refraction was: 8% myopia, 51% hyperopia and 41% astigmatism. The prevalence of refractive amblyopia risk factors was not significantly correlated with age, gender or prematurity, but with the presence of systemic disorders.

The PlusoptiX vision screener has proven to be sensitive and specific in detecting amblyopia risk factors and refractive errors [3]. Arnold et al reported sensitivity of PlusoptiX at 84%, and its specificity at 94% [18]. A more recent study reviewed 18 papers: the sensitivity ranged between 47% and 99%, and specificity from 49% to 100% [27]. The referral rate in our present study was 5.7% of those screened, very close to that determined in a similar study from the United Kingdom (5.6%) [28]. The referral rate in Hawaii using the same screener was however higher (8%), and that reported from China was lower (3.9%) [17, 19].

The prevalence of refractive amblyopia risk factors reported in the literature varies by the cut-off limits followed, method used, region where the study was performed, and age group studied. In Lebanon, only a single previous report looked into amblyopia risk factors in a cohort of 935 school children between the age of 5 and 18 years [29]. Visual acuity was solely tested, and “ametropia” was noted in 15.7% of the screened population, 70% of whom were unaware of their visual defect [29]. The prevalence of ametropia detected in our screened population was lower; however, our age group was narrower, and we had more stringent criteria based on automated vision screening, and not only subjective visual acuity which may be inaccurate in young subjects. An interesting study conducted in Australia looked at a cohort of predominantly Lebanese school children 10 to 15 years of age [30]. They aimed at detecting the prevalence rate of refractive errors among children of Middle Eastern descent (85.3% were Lebanese), raised and living in Australia [30]. This was the only previous study looking at refractive errors in a Lebanese cohort. A non-cycloplegic auto-refraction was conducted for 354 schoolchildren using the autorefractor NVision-K5001: 14.7% of the studied subjects were found to have myopia (sphere ≤-0.75D), and 21.8% had hyperopia (sphere ≥+1.50D) [30]. These numbers were closer to those of Australian origin than to those reported from the Middle Eastern region. The authors concluded that the prevalence of refractive errors tended to resemble that of the host country, suggesting that lifestyle and the education system had a higher impact on refractive errors than genetic and ethnic background [30]. The prevalence of refractive amblyopia risk factors in the current study are lower than those detected in this Lebanese cohort living in Melbourne, albeit with a different age group.

In Middle Eastern countries, the reported prevalence rates in general were higher than our current study. In Iranian children aged 7 to 12 years, prevalence rates of 4.9% for myopia, 3.5% for hyperopia and 22.6% for astigmatism were reported [20]. In Saudi Arabia, the prevalence rate of hyperopia was 1.5%, myopia 0.7% and astigmatism 25.3% [31]. In Jordan, children 12 to 17 years of age were screened; referral rate after vision screening was 25%, quite higher than ours at 5.7% [32]. The distribution of errors differed from ours with a higher prevalence of all refractive errors, mainly myopia, as compared to a dominance of hyperopia in our studied population. This can be attributed to the difference in the studied age groups, as hyperopia is more prevalent in younger children while myopia tends to increase with age.

The Vision In Preschoolers (VIP) study screened preschool children using several methods, including autorefractors and non-cycloplegic retinoscopy [33]. Hyperopia was seen in 2.5%, myopia in 0.1% and astigmatism in 4.4% [33] similar to our cohort. Another study in pre-school children (3 to 5 years of age) using the Retinomax autorefractor showed a referral rate of 8.9% and 74% of the examined patients needed glasses [34]. In the Baltimore Pediatric Eye Disease Study, myopia was found in 0.7% and hyperopia in 8.9% [35]. In Europe, the prevalence of the different types of refractive errors were higher than ours [36–38]. The prevalence of myopia is higher in the Far East as was demonstrated by the Strabismus, Amblyopia, and Refractive error in young Singaporean children (STARS) study in Singapore [39]. The prevalence rates were 11% for myopia, much higher than our present study, 1.4% for hyperopia, very close to the rate reported in this study and 8.6% for astigmatism, also higher than what we reported [39]. They concluded that change in prevalence may be influenced by ocular development, environment and testability of myopia [39]. A further study in Bhutan revealed a presence of 6.6% for myopia and 2.2% for hyperopia [40]. In India, a systematic review of 12 studies reported that the prevalence of refractive errors in children ≤15 years of age was: 1.4% for myopia, 4% for hyperopia and 1.1% for astigmatism [41]. In Chinese children of similar age to ours, prevalence rates were higher [42].

Our present study showed that there was no significant correlation between rate of referral and neither age nor gender. Hyperopia was the most prevalent refractive error in our examined population. One explanation is that young subjects with hyperopia are usually asymptomatic, and thus hyperopia goes mostly undetected in children. The prevalence of amblyopia risk factors and the distribution of refractive errors in the pediatric population vary widely in the reported literature. This is attributed to the absence of unified cut-off limits used to diagnose the different refractive errors. Add to that the differences in ethnic backgrounds of the study populations, age groups and the instruments/ methodology used. This precluded head-to-head comparison of our present work to those from the US, Europe, Asia and the rest of the Middle East.

This study has several strengths; it was conducted on a large sample size with over 1000 children screened. In addition, it was among the first studies to report refractive amblyopia risk factors in the Lebanese pediatric population. It thus provides an important reference for Lebanese pediatric ophthalmologists, and for international ophthalmologists to compare to. Referred patients underwent a full cycloplegic eye examination by the same pediatric ophthalmologist and the AAPOS Vision Screening Committee guidelines were followed for age-based refractive error targets. This study was conducted for a hospital-based population of Lebanese children. This factor, in addition to the limited sample size, served as a limitation, as the detected rates could not be generalized to the community. Another limitation was the low response rate of referral. Add to that, the PlusoptiX detects hyperopia with less sensitivity than it detects myopia and astigmatism (16). Thus, some false negative results might have been present but not detected. Also, we focused on a narrow age group within the sensitive period of visual development where the condition is amenable to patch therapy/ refractive adaptation and at an age where amblyopia has not yet become entrenched. The rates of systemic associated disorders among the referred subjects were higher than that in the non-referred group probably reflecting that our population came from a tertiary referral center. A wide difference was observed between the mean spherical equivalent of the photoscreener and cycloplegic refraction explained by the use of cycloplegia uncovering more hyperopia. A future community and school-based similar study including a wider age range is underway to reflect the true prevalence in our country.

In summary, using an automated vision screener in a hospital-based cohort of children aged 2 to 6 years, the prevalence of refractive amblyopia risk factors was 5.7%. Hyperopia was the most common refractive error, followed by astigmatism, then myopia. Age, gender, and prematurity were not found to significantly affect the referral rate, while a weak correlation was seen between systemic disorders and an increased risk of amblyopia risk factors.

Supporting information

S1 Data

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

This study was funded by the Medical Practice Plan (MPP) of the American University of Beirut awarded to CA (https://www.aub.edu.lb/fm/medicalresearch/Pages/ResearchFunding.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Zhang X, Wang Y, Huang D, Sun Q, Zhao X, Ding H, et al. Prevalence of reduced visual acuity among preschool children in eastern China and comparison at a 5-year interval. Clin Exp Ophthalmol. 2018;46(9):994–1001. Epub 2018/05/29. doi: 10.1111/ceo.13330 . [DOI] [PubMed] [Google Scholar]
  • 2.Force USPST. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement. Pediatrics. 2011;127(2):340–6. Epub 2011/02/02. doi: 10.1542/peds.2010-3177 . [DOI] [PubMed] [Google Scholar]
  • 3.Wallace DK, Morse CL, Melia M, Sprunger DT, Repka MX, Lee KA, et al. Pediatric Eye Evaluations Preferred Practice Pattern(R): I. Vision Screening in the Primary Care and Community Setting; II. Comprehensive Ophthalmic Examination. Ophthalmology. 2018;125(1):P184–P227. Epub 2017/11/08. doi: 10.1016/j.ophtha.2017.09.032 . [DOI] [PubMed] [Google Scholar]
  • 4.Moghaddam AA, Kargozar A, Zarei-Ghanavati M, Najjaran M, Nozari V, Shakeri MT. Screening for amblyopia risk factors in pre-verbal children using the Plusoptix photoscreener: a cross-sectional population-based study. Br J Ophthalmol. 2012;96(1):83–6. Epub 2011/04/26. doi: 10.1136/bjo.2010.190405 . [DOI] [PubMed] [Google Scholar]
  • 5.Pai AS, Rose KA, Leone JF, Sharbini S, Burlutsky G, Varma R, et al. Amblyopia prevalence and risk factors in Australian preschool children. Ophthalmology. 2012;119(1):138–44. Epub 2011/10/04. doi: 10.1016/j.ophtha.2011.06.024 . [DOI] [PubMed] [Google Scholar]
  • 6.Afsari S, Rose KA, Gole GA, Philip K, Leone JF, French A, et al. Prevalence of anisometropia and its association with refractive error and amblyopia in preschool children. The British journal of ophthalmology. 2013;97(9):1095–9. Epub 2013/04/25. doi: 10.1136/bjophthalmol-2012-302637 . [DOI] [PubMed] [Google Scholar]
  • 7.Aldebasi YH. Prevalence of amblyopia in primary school children in Qassim province, Kingdom of Saudi Arabia. Middle East African journal of ophthalmology. 2015;22(1):86–91. Epub 2015/01/28. doi: 10.4103/0974-9233.148355 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fu J, Li SM, Liu LR, Li JL, Li SY, Zhu BD, et al. Prevalence of amblyopia and strabismus in a population of 7th-grade junior high school students in Central China: the Anyang Childhood Eye Study (ACES). Ophthalmic epidemiology. 2014;21(3):197–203. Epub 2014/04/20. doi: 10.3109/09286586.2014.904371 . [DOI] [PubMed] [Google Scholar]
  • 9.Ganekal S, Jhanji V, Liang Y, Dorairaj S. Prevalence and etiology of amblyopia in Southern India: results from screening of school children aged 5–15 years. Ophthalmic epidemiology. 2013;20(4):228–31. Epub 2013/07/20. doi: 10.3109/09286586.2013.809772 . [DOI] [PubMed] [Google Scholar]
  • 10.Oscar A, Cherninkova S, Haykin V, Aroyo A, Levi A, Marinov N, et al. Amblyopia screening in Bulgaria. Journal of pediatric ophthalmology and strabismus. 2014;51(5):284–8. Epub 2014/06/28. doi: 10.3928/01913913-20140618-01 . [DOI] [PubMed] [Google Scholar]
  • 11.Ying GS, Maguire MG, Cyert LA, Ciner E, Quinn GE, Kulp MT, et al. Prevalence of vision disorders by racial and ethnic group among children participating in head start. Ophthalmology. 2014;121(3):630–6. Epub 2013/11/05. doi: 10.1016/j.ophtha.2013.09.036 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Donahue SP, Arnold RW, Ruben JB, Committee AVS. Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies. J AAPOS. 2003;7(5):314–6. Epub 2003/10/21. doi: 10.1016/s1091-8531(03)00182-4 . [DOI] [PubMed] [Google Scholar]
  • 13.Donahue SP, Nixon CN, Section on Opthamology AAoP, Committee on P, Ambulatory Medicine AAoP, American Academy of O, et al. Visual System Assessment in Infants, Children, and Young Adults by Pediatricians. Pediatrics. 2016;137(1):28–30. Epub 2016/01/01. doi: 10.1542/peds.2015-3596 . [DOI] [PubMed] [Google Scholar]
  • 14.Salcido AA, Bradley J, Donahue SP. Predictive value of photoscreening and traditional screening of preschool children. J AAPOS. 2005;9(2):114–20. Epub 2005/04/20. doi: 10.1016/j.jaapos.2003.10.011 . [DOI] [PubMed] [Google Scholar]
  • 15.Kirk VG, Clausen MM, Armitage MD, Arnold RW. Preverbal photoscreening for amblyogenic factors and outcomes in amblyopia treatment: early objective screening and visual acuities. Arch Ophthalmol. 2008;126(4):489–92. Epub 2008/04/17. doi: 10.1001/archopht.126.4.489 . [DOI] [PubMed] [Google Scholar]
  • 16.Webber AL, Wood J. Amblyopia: prevalence, natural history, functional effects and treatment. Clin Exp Optom. 2005;88(6):365–75. Epub 2005/12/07. doi: 10.1111/j.1444-0938.2005.tb05102.x . [DOI] [PubMed] [Google Scholar]
  • 17.Huang D, Chen X, Zhang X, Wang Y, Zhu H, Ding H, et al. Pediatric vision screening using the plusoptiX A12C photoscreener in Chinese preschool children aged 3 to 4 years. Sci Rep. 2017;7(1):2041. Epub 2017/05/19. doi: 10.1038/s41598-017-02246-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Arnold RW, Arnold AW, Armitage MD, Shen JM, Hepler TE, Woodard TL. Pediatric photoscreeners in high risk patients 2012: a comparison study of Plusoptix, Iscreen and SPOT. Binocul Vis Strabolog Q Simms Romano. 2013;28(1):20–8. Epub 2013/03/26. . [PubMed] [Google Scholar]
  • 19.Chang DA, Ede RC, Chow DC, Souza RD, Gangcuangco LM, Hanks N, et al. Early Childhood Vision Screening in Hawai’i Utilizing a Hand-Held Screener. Hawaii J Med Public Health. 2015;74(9):292–6. Epub 2015/10/16. . [PMC free article] [PubMed] [Google Scholar]
  • 20.Rajavi Z, Sabbaghi H, Baghini AS, Yaseri M, Moein H, Akbarian S, et al. Prevalence of Amblyopia and Refractive Errors Among Primary School Children. J Ophthalmic Vis Res. 2015;10(4):408–16. Epub 2016/04/07. . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Galvis V, Tello A, Otero J, Serrano AA, Gómez LM, Castellanos Y. Refractive errors in children and adolescents in Bucaramanga (Colombia). Arquivos brasileiros de oftalmologia. 2017;80(6):359–63. Epub 2017/12/22. doi: 10.5935/0004-2749.20170088 . [DOI] [PubMed] [Google Scholar]
  • 22.Galvis V, Tello A, Otero J, Serrano AA, Gómez LM, Camacho PA, et al. Prevalence of refractive errors in Colombia: MIOPUR study. The British journal of ophthalmology. 2018;102(10):1320–3. Epub 2018/06/28. doi: 10.1136/bjophthalmol-2018-312149 . [DOI] [PubMed] [Google Scholar]
  • 23.Fan DS, Lam DS, Lam RF, Lau JT, Chong KS, Cheung EY, et al. Prevalence, incidence, and progression of myopia of school children in Hong Kong. Investigative ophthalmology & visual science. 2004;45(4):1071–5. Epub 2004/03/24. doi: 10.1167/iovs.03-1151 . [DOI] [PubMed] [Google Scholar]
  • 24.Rim TH, Kim SH, Lim KH, Choi M, Kim HY, Baek SH. Refractive Errors in Koreans: The Korea National Health and Nutrition Examination Survey 2008–2012. Korean journal of ophthalmology: KJO. 2016;30(3):214–24. Epub 2016/06/02. doi: 10.3341/kjo.2016.30.3.214 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Saw SM, Carkeet A, Chia KS, Stone RA, Tan DT. Component dependent risk factors for ocular parameters in Singapore Chinese children. Ophthalmology. 2002;109(11):2065–71. Epub 2002/11/05. doi: 10.1016/s0161-6420(02)01220-4 [DOI] [PubMed] [Google Scholar]
  • 26.Donahue SP, Arthur B, Neely DE, Arnold RW, Silbert D, Ruben JB, et al. Guidelines for automated preschool vision screening: a 10-year, evidence-based update. J AAPOS. 2013;17(1):4–8. Epub 2013/01/31. doi: 10.1016/j.jaapos.2012.09.012 . [DOI] [PubMed] [Google Scholar]
  • 27.Tidbury LP OC A. The use of the plusoptiX photoscreener for vision screening. British and Irish Orthoptic Journal. 2015;10:11:6. [Google Scholar]
  • 28.Dahlmann-Noor AH, Vrotsou K, Kostakis V, Brown J, Heath J, Iron A, et al. Vision screening in children by Plusoptix Vision Screener compared with gold-standard orthoptic assessment. Br J Ophthalmol. 2009;93(3):342–5. Epub 2008/11/21. doi: 10.1136/bjo.2008.138115 . [DOI] [PubMed] [Google Scholar]
  • 29.M K. Étude exhaustive de la fréquence des troubles visuels chez les enfants âgés de 5 à 18 ans d’un collège libanais. Cahier d’étude et de recherches francophones / Santé 1996;6(5):323–6. [PubMed] [Google Scholar]
  • 30.Azizoglu S, Junghans BM, Barutchu A, Crewther SG. Refractive errors in students from Middle Eastern backgrounds living and undertaking schooling in Australia. Clin Exp Optom. 2011;94(1):67–75. Epub 2011/01/05. doi: 10.1111/j.1444-0938.2010.00563.x . [DOI] [PubMed] [Google Scholar]
  • 31.Alrahili NHR, Jadidy ES, Alahmadi BSH, Abdula’al MF, Jadidy AS, Alhusaini AA, et al. Prevalence of uncorrected refractive errors among children aged 3–10 years in western Saudi Arabia. Saudi Med J. 2017;38(8):804–10. Epub 2017/08/02. doi: 10.15537/smj.2017.8.20412 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Betaineh HA K A. Prevalence of refractive errors among children (12–17 years) of Tafila City. Sudanese Journal of Public Health. 2008;3(8):186–9. [Google Scholar]
  • 33.Schmidt P, Maguire M, Dobson V, Quinn G, Ciner E, Cyert L, et al. Comparison of preschool vision screening tests as administered by licensed eye care professionals in the Vision In Preschoolers Study. Ophthalmology. 2004;111(4):637–50. Epub 2004/03/31. doi: 10.1016/j.ophtha.2004.01.022 . [DOI] [PubMed] [Google Scholar]
  • 34.Steele G, Ireland D, Block S. Cycloplegic autorefraction results in pre-school children using the Nikon Retinomax Plus and the Welch Allyn SureSight. Optometry and vision science: official publication of the American Academy of Optometry. 2003;80(8):573–7. Epub 2003/08/15. doi: 10.1097/00006324-200308000-00010 . [DOI] [PubMed] [Google Scholar]
  • 35.Giordano L, Friedman DS, Repka MX, Katz J, Ibironke J, Hawes P, et al. Prevalence of refractive error among preschool children in an urban population: the Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009;116(4):739–46, 46 e1–4. Epub 2009/02/27. doi: 10.1016/j.ophtha.2008.12.030 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.O’Donoghue L S K, McClelland JF, Logan NS, Rudnicka AR, Owen CG. Prevalence of Childhood Refractive Error in the United Kingdom. Investigative Ophthalmology & Visual Science 2009;50(13):2562. [Google Scholar]
  • 37.Polling JR, Loudon SE, Klaver CC. Prevalence of amblyopia and refractive errors in an unscreened population of children. Optom Vis Sci. 2012;89(11):e44–9. Epub 2012/10/17. doi: 10.1097/OPX.0b013e31826ae047 . [DOI] [PubMed] [Google Scholar]
  • 38.Gronlund MA, Andersson S, Aring E, Hard AL, Hellstrom A. Ophthalmological findings in a sample of Swedish children aged 4–15 years. Acta Ophthalmol Scand. 2006;84(2):169–76. Epub 2006/04/28. doi: 10.1111/j.1600-0420.2005.00615.x . [DOI] [PubMed] [Google Scholar]
  • 39.Dirani M, Chan YH, Gazzard G, Hornbeak DM, Leo SW, Selvaraj P, et al. Prevalence of refractive error in Singaporean Chinese children: the strabismus, amblyopia, and refractive error in young Singaporean Children (STARS) study. Invest Ophthalmol Vis Sci. 2010;51(3):1348–55. Epub 2009/11/26. doi: 10.1167/iovs.09-3587 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sharma IP, Lepcha NT, Lhamo T, Ellwein LB, Pokharel GP, Das T, et al. Visual impairment and refractive error in school children in Bhutan: The findings from the Bhutan School Sight Survey (BSSS 2019). PLoS One. 2020;15(9):e0239117. Epub 2020/09/15. doi: 10.1371/journal.pone.0239117 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sheeladevi S, Seelam B, Nukella PB, Modi A, Ali R, Keay L. Prevalence of refractive errors in children in India: a systematic review. Clin Exp Optom. 2018;101(4):495–503. Epub 2018/04/24. doi: 10.1111/cxo.12689 . [DOI] [PubMed] [Google Scholar]
  • 42.Lan W, Zhao F, Lin L, Li Z, Zeng J, Yang Z, et al. Refractive errors in 3–6 year-old Chinese children: a very low prevalence of myopia? PLoS One. 2013;8(10):e78003. Epub 2013/11/10. doi: 10.1371/journal.pone.0078003 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ahmed Awadein

17 Mar 2021

PONE-D-21-00998

Refractive Errors among Pediatric Patients in a Hospital-Based Setting Using Photoscreening

PLOS ONE

Dear Dr. Al-Haddad,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

The manuscript has many fundamental issues that need meticulous revision.

1- The manuscript needs English editing for grammar and style

2- Some sections such as the introduction section are too long and contain unnecessary data while the results section needs more details

3- The fact that refractive errors were diagnosed with photoscreening rather than a more accurate method like retinoscopy or conventional autorefractors should be addressed. The authors might consider using the term "detection of amblyopia risk factors" rather than "refractive errors"

==============================

Please submit your revised manuscript by Apr 16 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Ahmed Awadein, MD, Ph.D, FRCS

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2) We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: No

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have one fundamental objection against methodology of this study: I do not agree that photoscreener can be used for evaluation of refractive error prevalence, and this is also showed by the results of this study. It is however accepted that it is used in screening of amblyopia risk factors. Because of that the whole study, to be accepted for publication, must be completely re-written. Moreover, I do not think that referral rate is so much interesting as long as you did not analyze also all negative cases. However, verification with complete ophthalmic examination and cycloplegia refraction of positive cases is very interesting issue and could a subject for a separate article in the future.

Reviewer #2: This study shows the results of hospital-based screening of Lebanese pediatric patients 2-6 years regarding amblyogenic refractive errors and the results of subsequent comprehensive ophthalmic evaluation. There are some concerns regarding methodology and end results.

1. The manuscript needs significant English language editing.

2. The “INTRODUCTION” section is very confusing and contains lots of unnecessary data. Specifically, the second paragraph should be totally rephrased. The whole “INTRODUCTION” section should be 2 to 3 paragraphs describing in brief background and the aim of the study.

3. The authors did not mention the period of time during which the study was conducted.

4. In “RESULTS” section, the authors mentioned that only 59% of their referred cases were examined at their facility, without mentioning where the rest of referred cases (31%) were examined?

Reviewer #3: A very nice, respectful and valuable work that is worthy more evaluation with a larger number of patients for a better benefit.

29 prevalence (would be better than rate)

73-76 If you would like to rephrase.

129-133 Table 1 AAPOS ARFs (if you would like to mention ; limit of astigmatism 90/180 Vs oblique one ?, type of anisometropia)

140 Was CRx performed by the same examiner ?

141,142 Source of this rational of cycloplegia ?

174 37/63 were examined at your department. What about the remainder ?

312 "still be treated" Do you mean amblyopia ttt with refractive adaptation only or in general ?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 29;16(7):e0254831. doi: 10.1371/journal.pone.0254831.r002

Author response to Decision Letter 0


21 Apr 2021

ACADEMIC EDITOR:

The manuscript has many fundamental issues that need meticulous revision.

1- The manuscript needs English editing for grammar and style

We have revised thoroughly the whole manuscript for grammatical and linguistic errors/ style.

2- Some sections such as the introduction section are too long and contain unnecessary data while the results section needs more details

The introduction was made more succinct and only relevant data were kept. The results section was elaborated more on.

3- The fact that refractive errors were diagnosed with photoscreening rather than a more accurate method like retinoscopy or conventional autorefractors should be addressed. The authors might consider using the term "detection of amblyopia risk factors" rather than "refractive errors"

Thank you for the comment, the authors agree and have modified the title and manuscript text to use “amblyopia risk factors” rather than “refractive errors.”

Reviewer #1: I have one fundamental objection against methodology of this study: I do not agree that photoscreener can be used for evaluation of refractive error prevalence, and this is also showed by the results of this study. It is however accepted that it is used in screening of amblyopia risk factors. Because of that the whole study, to be accepted for publication, must be completely re-written. Moreover, I do not think that referral rate is so much interesting as long as you did not analyze also all negative cases. However, verification with complete ophthalmic examination and cycloplegia refraction of positive cases is very interesting issue and could a subject for a separate article in the future.

We thank the reviewer. We have modified accordingly the title to “Amblyopia Risk Factors among Pediatric Patients in a Hospital-Based Setting Using Photoscreening;” additionally, we revised the manuscript text to reflect our aim as detection of amblyopia risk factors in children visiting our medical center rather than prevalence of refractive errors. We agree that reporting the validation of photoscreening positive results by cycloplegic refraction will be an interesting topic in a future study.

Reviewer #2: This study shows the results of hospital-based screening of Lebanese pediatric patients 2-6 years regarding amblyogenic refractive errors and the results of subsequent comprehensive ophthalmic evaluation. There are some concerns regarding methodology and end results.

1. The manuscript needs significant English language editing.

We have revised the whole manuscript for grammatical and linguistic errors.

2. The “INTRODUCTION” section is very confusing and contains lots of unnecessary data. Specifically, the second paragraph should be totally rephrased. The whole “INTRODUCTION” section should be 2 to 3 paragraphs describing in brief background and the aim of the study.

The introduction was made more succinct and relevant points were kept. Specifically paragraph 2 was rephrased and the whole introduction was shortened.

3. The authors did not mention the period of time during which the study was conducted.

The study was conducted over a time span of 2 years (2018-2020), this was added to the methods section.

4. In “RESULTS” section, the authors mentioned that only 59% of their referred cases were examined at their facility, without mentioning where the rest of referred cases (31%) were examined?

The rest of referred cases were lost to follow up after multiple attempts to schedule an ophthalmology appointment. This was now added to the text for clarification.

Reviewer #3: A very nice, respectful and valuable work that is worthy more evaluation with a larger number of patients for a better benefit.

We thank the reviewer for their positive feedback and appreciate their comment, indeed we plan on a larger scale “school-based” prevalence study when time permits.

29 prevalence (would be better than rate)

Thank you, it was corrected accordingly.

73-76 If you would like to rephrase.

The section was rephrased for better clarity to the reader.

129-133 Table 1 AAPOS ARFs (if you would like to mention ; limit of astigmatism 90/180 Vs oblique one ?, type of anisometropia)

Although it has been reported that oblique astigmatism constitutes a greater amblyopia risk factor than regular astigmatism, the guidelines published by the AAPOS Vision Screening Committee (JAAPOS 2013;17:4-8, Table 1: AAPOS ARFs), which we have followed in this study, did not differentiate by the axis of astigmatism, but rather used the magnitude in Diopters. Similarly, for anisometropia, only the absolute value in diopters was used.

140 Was CRx performed by the same examiner?

Yes the same pediatric ophthalmologist (author C Al-Haddad) examined all referred patients, this is now mentioned explicitly in the methods section.

141,142 Source of this rational of cycloplegia ?

Thank you for your comment. In this clinic, we use two sets of dilating drops as a standard especially with darker irides (which constitute a good portion of our population, below references). This was added to our methods section.

References :

Farhood, Q. K. (2012). Cycloplegic refraction in children with cyclopentolate versus atropine. J Clin Exp Ophthalmol, 3(7), 1-6.

Wallace, D. K., Morse, C. L., Melia, M., Sprunger, D. T., Repka, M. X., Lee, K. A., & Christiansen, S. P. (2018). Pediatric eye evaluations preferred practice Pattern®: I. vision screening in the primary care and community setting; II. comprehensive ophthalmic examination. Ophthalmology, 125(1), P184-P227.

174 37/63 were examined at your department. What about the remainder ?

The rest of referred cases were lost to follow up after multiple attempts to schedule an ophthalmology appointment. This was now added to the text.

312 "still be treated" Do you mean amblyopia ttt with refractive adaptation only or in general ?

This was clarified in text: “within the sensitive period of visual development, while still amenable to patch therapy/ refractive adaptation and at an age where amblyopia has not yet become entrenched”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Ahmed Awadein

2 Jun 2021

PONE-D-21-00998R1

Amblyopia Risk Factors among Pediatric Patients in a Hospital-Based Setting Using Photoscreening

PLOS ONE

Dear Dr. Al-Haddad,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

Most of the comments were properly addressed. There are only few comments mentioned below that should be addressed.

==============================

Please submit your revised manuscript by Jul 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ahmed Awadein, MD, Ph.D, FRCS

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for revising the ms that is now significantly improved.

Reviewer #3: (No Response)

Reviewer #4: 1- Abstract: Results "The refractive errors among the referred patients were: 41% astigmatism, 51% hyperopia, and 8% myopia, with no amblyopia detected on eye examination.: Needs rephrasing

2- Add reference to Table 1

3- Methods: “for verbal children; anterior segment examination; motility examination for any eye misalignment; cycloplegic manual retinoscopy to detect refractive errors (30 minutes after pupillary dilation with Mydriacyl 1% and Cyclopentolate 1%, applied twice 10 minutes apart, in this clinic, we use two sets as a standard especially with darker irides); The sentence needs grammatical revision. It also starts with small letter

4- Results: "Out of the 37 examined children, 19 had hyperopia, 15 had astigmatism and 3 subjects were myopic." So do this means that none of the patients had both spherical and cylindrical error at the same time?

5- While correlation was done to compare the readings of autorefractor and retinoscopy, the correct statistical analysis would to use an agreement statistics e.g. Bland-Altman plot and Deming regression analysis

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Andrzej Grzybowski, MD, PhD

Reviewer #3: Yes: Ahmed Taha Ismail

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 29;16(7):e0254831. doi: 10.1371/journal.pone.0254831.r004

Author response to Decision Letter 1


28 Jun 2021

June 28, 2021

Dear Dr Chenette and PLOS ONE Editorial Board,

Thank you for your response to our revision on our manuscript entitled "Amblyopia Risk Factors among Pediatric Patients in a Hospital-Based Setting Using Photoscreening". We appreciate the time and effort that has gone into reviewing our manuscript and thank you for the valuable comments.

Please find below a point-by-point reply to the reviewer comments. Comments are copied verbatim, followed immediately by our response.

Reviewer #4:

1- Abstract: Results "The refractive errors among the referred patients were: 41% astigmatism, 51% hyperopia, and 8% myopia, with no amblyopia detected on eye examination.: Needs rephrasing

This sentence was rephrased as follows:

The refractive errors observed among the examined patients were distributed as follows: 41% astigmatism, 51% hyperopia, and 8% myopia; amblyopia was not detected.

2- Add reference to Table 1

Reference was added to the table title.

3- Methods: “for verbal children; anterior segment examination; motility examination for any eye misalignment; cycloplegic manual retinoscopy to detect refractive errors (30 minutes after pupillary dilation with Mydriacyl 1% and Cyclopentolate 1%, applied twice 10 minutes apart, in this clinic, we use two sets as a standard especially with darker irides); The sentence needs grammatical revision. It also starts with small letter

We agree that this was a long run-on sentence. It was reworded as follows:

This entailed age-dependent visual acuity testing: “central steady & maintained” testing for preverbal children and vision charts (Allen pictures and Early Treatment Diabetic Retinopathy Study charts (EDTRS)) for verbal children. Anterior segment examination, motility examination for any eye misalignment, and posterior segment examination using indirect ophthalmoscopy were performed. Cycloplegic manual retinoscopy was done to detect refractive errors (30 minutes after pupillary dilation with Mydriacyl 1% and Cyclopentolate 1%, applied twice 10 minutes apart; in this clinic, we use two sets as a standard especially with darker irides).

4- Results: "Out of the 37 examined children, 19 had hyperopia, 15 had astigmatism and 3 subjects were myopic." So do this means that none of the patients had both spherical and cylindrical error at the same time?

Thank you for your comment. As we mentioned in the Methods section:

“Significant astigmatism was defined as cylindrical power of 1D or more with the main refractive error being the cylinder. Those reported with hyperopia and myopia had mainly spherical refractive error (>+1D or <-1D, respectively).”

Thus, the patients were subdivided based on the predominant refractive error detected when both spherical and cylindrical errors co-existed.

5- While correlation was done to compare the readings of autorefractor and retinoscopy, the correct statistical analysis would to use an agreement statistics e.g. Bland-Altman plot and Deming regression analysis

Thank you for your comment. We agree that an agreement statistic would strengthen our study. We thus added a Bland-Altman plot to our paper.

Attachment

Submitted filename: Response to Reviewers .docx

Decision Letter 2

Ahmed Awadein

5 Jul 2021

Amblyopia Risk Factors among Pediatric Patients in a Hospital-Based Setting Using Photoscreening

PONE-D-21-00998R2

Dear Dr. Al-Haddad,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ahmed Awadein, MD, Ph.D, FRCS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Ahmed Awadein

12 Jul 2021

PONE-D-21-00998R2

Amblyopia Risk Factors among Pediatric Patients in a Hospital-Based Setting Using Photoscreening

Dear Dr. Al-Haddad:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ahmed Awadein

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers .docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES